Quantitative Mammographic Density Measurements and Molecular Subtypes in Chinese Women With Breast Cancer. Issue 1 (13th October 2020)

• Record Type: Journal Article
• Authors: Tian, Yuan; Guida, Jennifer L; Koka, Hela; Li, Er-Ni; Zhu, Bin; Sung, Hyuna; Chan, Ariane; Zhang, Han; Tang, Eric; Guo, Changyuan; Deng, Joseph; Hu, Nan; Lu, Ning; Gierach, Gretchen L; Li, Jing; Yang, Xiaohong R
• Is Part Of: JNCI cancer spectrum. Volume 5:Issue 1(2021)
• Publication Date: 2020-10-13
• DOI: 10.1093/jncics/pkaa092
• Languages: English
• ISSNs: 2515-5091

Abstract

Abstract: Background: Studies investigating associations between mammographic density (MD) and breast cancer subtypes have generated mixed results. We previously showed that having extremely dense breasts was associated with the human epidermal growth factor receptor-2 (HER2)-enriched subtype in Chinese breast cancer patients. Methods: In this study, we reevaluated the MD-subtype association in 1549 Chinese breast cancer patients, using VolparaDensity software to obtain quantitative MD measures. All statistical tests were 2-sided. Results: Compared with women with luminal A tumors, women with luminal B/HER2- (odds ratio [OR] = 1.20, 95% confidence interval [CI] = 1.04 to 1.38; P = .01), luminal B/HER2+ (OR = 1.22, 95% CI = 1.03 to 1.46; P = .03), and HER2-enriched tumors (OR = 1.30, 95% CI = 1.06 to 1.59; P = .01) had higher fibroglandular dense volume. These associations were stronger in patients with smaller tumors (<2 cm). In contrast, the triple-negative subtype was associated with lower nondense volume (OR = 0.82, 95% CI = 0.68 to 0.99; P = .04), and the association was only seen among older women (age 50 years or older). Conclusion: Although biological mechanisms remain to be investigated, the associations for the HER2-enriched and luminal B subtypes with increasing MD may partially explain the higher prevalence of luminal B and HER2+ breast cancers previously reported in Asian women.